Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant MelanomaMayinuer Maitituoheti, Kunal Rai, Tara Shah et al.|Cell Reports|2020Cited by 70
Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategyChristopher Terranova, Kunal Rai, Ming Tang et al.|Cell Reports|2021Cited by 31
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF signaling in KMT2D Mutant MelanomaMayinuer Maitituoheti, Kunal Rai, Emily Z. Keung et al.|bioRxiv (Cold Spring Harbor Laboratory)|2018Cited by 8
Bivalent and Broad Chromatin Domains Regulate Pro-metastatic Drivers in MelanomaChristopher Terranova, Kunal Rai, Ming Tang et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 5
Enhancer Reprogramming in Melanoma Immune Checkpoint Therapy ResistanceMayinuer Maitituoheti, Kunal Rai, Alvin Shi et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 4